News

Couldn't resolve component "default" at "/:pathMatch (.*)?/:lcsId ( [0-9]\- [0-9]\- [0-9]+| [0-9]- [0-9]- [0-9]+PT [0-9]+)" ...
(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.
Game wardens with the Georgia Department of Natural Resources (DNR) assisted in fishing a suspect out of the water on Monday, June 1. Emergency crews responded to two separate car accidents on ...
The scheme resulted in the redirection of a valid payment to a fraudulent account. A person impersonating the chief financial officer of a legitimate vendor contacted the city with a request to ...
Wexford County Council (WCC) is to hold a second public participation day this summer as it continues plans to develop a coastal erosion scheme in Rosslare Strand. Expected to be completed in ...
The IPO had been marketed in a range of $27 to $28 per share. Sign up here. The company's flotation would rank among the biggest of the year, following a period of market uncertainty sparked by ...
We’ve teamed up with world number one in cookware*, Tefal, to give three lucky winners the chance to win the best-selling 22-piece Ingenio Emotion Cookware set worth £375. The ultimate cookware ...
By posting on our share chat boards you are agreeing to the ... as the Rosebank and Jackdaw fields went ahead, as well as other schemes. Prof De Leeuw suggested ministers could try to grow ...
Most defined benefit (DB) pension schemes are either already planning to share surplus funds or will consider doing so soon, according to an upcoming LCP survey. Larger schemes are particularly ...
More than half of defined benefit (DB) pension schemes are already actively considering sharing ... 20 per cent said there would be no impact as they are already planning to share or distribute their ...
AstraZeneca PLC (LSE/STO/NASDAQ:LON:AZN) has released its block listing interim review, detailing the status of its share schemes as of June 2, 2025. The pharmaceutical company, headquartered in ...
AstraZeneca PLC (LSE/STO/NASDAQ:LON: AZN) has released its block listing interim review, detailing the status of its share schemes as of June 2, 2025.The pharmaceutical company, headquartered in ...